What does CUSIP 71880W204 represent in this 13F holders report?

CUSIP 71880W204 is the security identifier for PHIO - PHIO PHARMACEUTICALS CORP - COM used to aggregate holder disclosures.

How many institutions held PHIO - PHIO PHARMACEUTICALS CORP - COM in Q4 2019?

7 institutional investors reported PHIO - PHIO PHARMACEUTICALS CORP - COM for Q4 2019. Use the holders table for investor-level position and value details.

PHIO PHARMACEUTICALS CORP - COM (PHIO)

CUSIP: 71880W204

Q4 2019 13F Holders as of 31 Dec 2019

Security type / class: Equity / COM
Total 13F shares: 1,324,463
Total 13F value: $646,001
Share change: +386,113
SEC-reported price per share: $0.18
Number of holders: 7
Value change: +$179,475
Number of buys: 5
Number of sells: 2

Security key

71880W204

Report period

Q4 2019

Institutions

Top holders

PHIO full security history Ownership snapshot Full 13F holder table Phio Pharmaceuticals Corp. SEC filings Phio Pharmaceuticals Corp. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of PHIO - PHIO PHARMACEUTICALS CORP - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

SG Americas Securities, LLC

Disclosed value leader

SG Americas Securities, LLC

Comparable rows

0/8

Latest evidence

30 Sep 2019

13F Highest disclosed value: $194,000 8 rows are not safely comparable across share classes. Showing 1-6 of 8 holder rows.

Quick read

SG Americas Securities, LLC has the largest disclosed position value at $194K.

0 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SG Americas Securities, LLC's linked filing trail.

Disclosed position value Top 5

SG Americas Securities, LLC $194K

CVI Holdings, LLC $26K

RENAISSANCE TECHNOLOGIES LLC $13K

SUSQUEHANNA INTERNATIONAL GROUP, LLP $9K

UBS Group AG $9K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 8 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
SG Americas Securities, LLC	13F Company 13F	— denominator unverified	$194,000 705,353 shares	—	30 Sep 2019
CVI Holdings, LLC	13F Company 13F	— denominator unverified	$26,000 93,081 shares	—	30 Sep 2019
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— denominator unverified	$13,000 48,677 shares	—	30 Sep 2019
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F Company 13F	— denominator unverified	$9,000 33,079 shares	—	30 Sep 2019
UBS Group AG	13F Company 13F	— denominator unverified	$9,000 31,695 shares	—	30 Sep 2019
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$7,000 26,460 shares	—	30 Sep 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,324,463

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders

Q4 2019 holders

Holder diff

Investor	Q3 2019 Shares	Q4 2019 Shares	Share Diff	Share Chg %	Q3 2019 value	Q4 2019 value	Value change	Value Chg %